Bob Duggan boosts Summit Technologies stake with $50 million investment, Grant Cardone notes

Bob Duggan boosts Summit Technologies stake with $50 million investment, Grant Cardone notes
Bob Duggan adds $50 million to Summit

Grant Cardone, CEO / Founder — Cardone Enterprises; Founder & CEO — Cardone Capital (real estate investment platform), reports that Bob Duggan, CEO of cancer drug developer Summit Technologies (SMMT), is investing an additional $50 million into his company. Duggan, formerly CEO of Pharmacyclics, previously sold that company to Abbvie for $21 billion in cash. Duggan reportedly holds a personal net worth of $14 billion and already owns 580 million shares of Summit Technologies.

Cardone has addressed large asset movements in previous commentary. He recently highlighted Saylor’s sale of 32 BTC out of more than 843,000, noting the sale represented only a small fraction of total holdings. In a separate post, Cardone stated that the recent Bitcoin selloff driven by AI adoption was not tied to underlying business fundamentals.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.